IndraLab
Statements
reach
"Immunogenic ferroptosis induced by BEBT-908 (PI3K inhibitor) leads to upregulation of major histocompatibility complex I (MHC-I) and activation of endogenous IFN-γ via STAT1, thereby activating the antitumor immune response and enhancing anti-PD1 therapy, effectively inhibits tumor growth [171]."